PDPN and head and neck squamous cell carcinoma: In head and neck squamous cell carcinomas, ezrin was identified as a key molecule in tumor progression and metastatic behavior of neoplastic cells and it has been correlated with poor outcome [18–21], similarly to podoplanin [22].